SCHEMBL4300481

SCHEMBL4300481

CCCCCCCCCCc1ccc(CN2CCC(C(=O)O)(C(=O)OCC)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
S1PR1 P21453 3/20 0.52
S1PR3 Q99500 3/20 0.52
S1PR4 O95977 2/20 0.52
S1PR5 Q9H228 2/20 0.52
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
POLB P06746 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.50
HRH3 Q9Y5N1 2/20 0.50
OPRM1 P35372 2/20 0.49
OPRD1 P41143 2/20 0.49
ALDH1A1 P00352 2/20 0.48
PKM P14618 1/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
KCNA3 P22001 1/20 0.48
HTT P42858 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4293459 0.94 LMNA (0.54) LMNAS1PR1S1PR3S1PR4S1PR5
SCHEMBL4298783 0.89 S1PR1 (0.60) S1PR1S1PR3S1PR4S1PR5KMT2A
SCHEMBL4289421 0.89 S1PR1 (0.60) S1PR1S1PR3S1PR4S1PR5KMT2A
SCHEMBL4300178 0.89 S1PR1 (0.60) S1PR1S1PR3S1PR4S1PR5KMT2A
SCHEMBL5797072 0.89 S1PR1 (0.60) S1PR1S1PR3S1PR4S1PR5KMT2A
SCHEMBL5796299 0.87 RARB (0.50) LMNAS1PR1S1PR3S1PR4S1PR5
SCHEMBL4287372 0.87 RARB (0.52) LMNAS1PR1S1PR3S1PR4S1PR5
SCHEMBL4290739 0.84 S1PR1 (0.54) LMNAS1PR1S1PR3S1PR4S1PR5
SCHEMBL4288452 0.83 KMT2A (0.58) LMNAS1PR5KMT2AMEN1L3MBTL1
SCHEMBL4287254 0.83 S1PR1 (0.53) S1PR1S1PR3S1PR4S1PR5HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264469-A1 NOVEL DICARBOXYLIC ACID DERIVATIVES BIO-PROJET (FR) 2009-10-22 US claimed
US-20090264469-A1 NOVEL DICARBOXYLIC ACID DERIVATIVES BIO-PROJET (FR) 2009-10-22 US disclosed
WO-2006043149-A9 NOVEL DICARBOXYLIC ACID DERIVATIVES BIOPROJET SOC CIV (FR) 2006-08-10 WO disclosed
WO-2006043149-A2 NOVEL DICARBOXYLIC ACID DERIVATIVES BIOPROJET (FR) 2006-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264469-A1 NOVEL DICARBOXYLIC ACID DERIVATIVES S1PR2, S1PR1, S1PR5 LMNA 4220/4885S1PR1 2/4885S1PR3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.